BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Innocoll, Inc. Announces Launch of Its New CollaCare® Website


2/19/2013 10:19:35 AM

ASHBURN, Va., Feb. 19, 2013 /PRNewswire/ -- Innocoll, Inc. announced the launch of its new CollaCare website, www.collacareproducts.com. The new, standalone website is designed to be the primary source of information on the full range of products in the CollaCare family for patients, practitioners and marketing partners. All key information on the product family has been incorporated onto the website in a readily accessible and user friendly manner.

Innocoll's CollaCare portfolio of products consists of sterile, biodegradable, advanced wound management devices, wound dressings, topical anesthetics, dental and skin care products that cover a broad range of indications.

Commenting on the announcements, Dr. Michael Myers, Innocoll's President and CEO said, "We are very pleased to announce the launch of this new website. Given the broad range of products within the CollaCare family, we believe that a standalone website is merited." Dr. Myers further commented, "We have seen how valuable a resource our CollaGUARD adhesion barrier website has become and look forward to a similar outcome for CollaCare."

About CollaCare

The CollaCare products were developed using Innocoll's proprietary collagen based technologies. The products are versatile, easy to handle, fully resorbable and cover a broad range of indications and therapeutic areas.

The CollaCare portfolio of wound management products include regenerative dressings to treat chronic and acute wounds; pressure ulcers, venous stasis ulcers, diabetic ulcers and burns; topical powders that absorb wound exudate, and dental sponges for use during oral and maxillofacial surgeries.

  • CollaCare Sponge
  • Collexa
  • ProColl
  • CollaCare Powder
  • CollaCare Dental

About Innocoll, Inc.

Innocoll is a privately held, biopharmaceutical company focused on biodegradable surgical implants and topically applied healthcare products. The company develops and manufactures a range of pharmaceutical products and medical devices using its proprietary collagen-based technologies, CollaRx®, CollaFilm, DermaSil, CollaPress and Liquicoll®.

Approved products based on the Company's technologies include: Collatamp® G, Septocoll®, CollaGUARD®, Collieva®, CollaCare®, Collexa®, Zorpreva, and LidoColl®.

Products in clinical and regulatory development include: Cogenzia® in phase 3 for the adjuvant treatment of infected diabetic foot ulcers, XaraColl® in phase 3 development for the management of post-operative pain and Durieva, a dura on-lay/ dura replacement product. For more information, please visit www.innocollinc.com.

SOURCE Innocoll, Inc.



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES